MustGrow Biologics reports jump in revenue as TerraSante US sales drive growth

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF, FRA:0C0) has reported a crisp summation successful gross for 2025 arsenic it expanded its biologic and regenerative agriculture offering.

For the twelvemonth ended December 31, 2025, the institution generated income gross of $8.3 million, up from $0.4 cardinal successful 2024, reflecting accrued commercialized activity, peculiarly for its TerraSante biofertility merchandise successful the United States.

US income of TerraSante reached $0.6 cardinal successful 2025, a 377% summation from conscionable implicit $0.1 cardinal successful the anterior year, with a reported gross borderline of 20%.

Operating expenses roseate to $7.7 cardinal from $5.4 cardinal a twelvemonth earlier, chiefly owed to the outgo of moving the NexusBioAg Canadian income division. Net nonaccomplishment for the twelvemonth widened to $7.3 million, compared with $4.9 cardinal successful 2024.

MustGrow CEO Corey Giasson said the company’s efforts successful 2025 were centered connected preparing for accrued request successful the US market.

“Throughout 2025, absorption focused connected securing superior and expanding third-party manufacturing capableness to hole for increasing TerraSanteTM request successful the US,” helium said.

He added that the determination to unopen down the Canadian organisation portion was aimed astatine reallocating resources toward scaling production. Giasson described the determination arsenic “a cardinal strategical decision” intended to enactment the company’s absorption connected TerraSante.

Demand for the merchandise exceeded disposable proviso during the year, contributing to the beardown maturation successful US sales, helium noted.

Looking ahead, Giasson said the institution expects further income maturation and improved margins arsenic accumulation processes germinate and outer conditions go much favorable.

“For 2026, we expect continued maturation successful TerraSanteTM income and an betterment successful gross margins with much favourable U.S. tariffs and arsenic we displacement from tiny standard batch accumulation to continuous accumulation with our declaration manufacturers,” helium said.

He added that MustGrow is besides exploring opportunities to grow TerraSante into caller planetary markets wherever regulatory pathways whitethorn let for faster commercialization.